We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
31 hedge funds and large institutions have $257M invested in ESSA Pharma in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
149% more capital invested
Capital invested by funds: $103M → $257M (+$154M)
124% more call options, than puts
Call options by funds: $360K | Put options by funds: $161K
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
12.37% more ownership
Funds ownership: 75.89% → 88.26% (+12%)
14% less funds holding
Funds holding: 36 → 31 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
31
Holders Change
-5
Holders Change %
-13.89%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
10
Reduced
6
Closed
9
Calls
$360K
Puts
$161K
Net Calls
+$199K
Net Calls Change
+$331K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$20.6M |
| 2 |
RI
RTW Investments
New York
|
+$11.3M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$5.37M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.27M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$460K |
